New personalized combo could spare surgery for stomach cancer patients
Disease control
Not yet recruiting
This study tests a personalized treatment approach for people with stomach or esophageal cancer. It uses tumor biomarkers to match each patient with a combination of chemotherapy, immunotherapy, and targeted drugs. The goal is to improve response and, in some cases, allow patient…
Phase: PHASE2 • Sponsor: American Association for Cancer Research • Aim: Disease control
Last updated May 20, 2026 11:54 UTC